Free Trial

Nuveen LLC Acquires Shares of 142,161 Cross Country Healthcare, Inc. $CCRN

Cross Country Healthcare logo with Business Services background

Key Points

  • Nuveen LLC has acquired 142,161 shares in Cross Country Healthcare, Inc. for approximately $2.1 million, representing 0.43% ownership in the company.
  • Cross Country Healthcare reported a quarterly earnings miss, with an EPS of ($0.01) against a consensus estimate of $0.07, and revenue of $274.07 million, below expectations.
  • As of now, Cross Country Healthcare has a consensus rating of "Hold" from six research analysts, with a target price of $17.93.
  • Five stocks to consider instead of Cross Country Healthcare.

Nuveen LLC bought a new stake in shares of Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 142,161 shares of the business services provider's stock, valued at approximately $2,117,000. Nuveen LLC owned 0.43% of Cross Country Healthcare as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently bought and sold shares of CCRN. Alpine Associates Management Inc. lifted its position in Cross Country Healthcare by 115.6% during the first quarter. Alpine Associates Management Inc. now owns 1,252,524 shares of the business services provider's stock valued at $18,650,000 after acquiring an additional 671,492 shares during the last quarter. D. E. Shaw & Co. Inc. lifted its holdings in shares of Cross Country Healthcare by 35.1% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 524,807 shares of the business services provider's stock valued at $9,530,000 after purchasing an additional 136,374 shares during the last quarter. Millennium Management LLC boosted its position in shares of Cross Country Healthcare by 657.5% in the 4th quarter. Millennium Management LLC now owns 405,600 shares of the business services provider's stock worth $7,366,000 after purchasing an additional 352,056 shares in the last quarter. Charles Schwab Investment Management Inc. grew its stake in Cross Country Healthcare by 27.7% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 402,230 shares of the business services provider's stock worth $5,989,000 after buying an additional 87,353 shares during the last quarter. Finally, Pacer Advisors Inc. acquired a new position in shares of Cross Country Healthcare in the 1st quarter valued at $5,853,000. Institutional investors own 96.03% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on the stock. UBS Group dropped their price objective on shares of Cross Country Healthcare from $18.61 to $16.50 and set a "neutral" rating on the stock in a research note on Tuesday, May 13th. Wall Street Zen raised shares of Cross Country Healthcare to a "hold" rating in a research note on Saturday, August 9th. Finally, Barrington Research reissued a "market perform" rating and set a $18.61 price objective on shares of Cross Country Healthcare in a research note on Tuesday, June 17th. Six investment analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Cross Country Healthcare has an average rating of "Hold" and a consensus price target of $17.93.

View Our Latest Stock Analysis on CCRN

Cross Country Healthcare Stock Performance

Shares of CCRN traded down $0.51 during mid-day trading on Wednesday, hitting $12.78. The company's stock had a trading volume of 110,347 shares, compared to its average volume of 335,740. The stock's 50-day moving average is $13.09 and its two-hundred day moving average is $14.09. Cross Country Healthcare, Inc. has a one year low of $9.58 and a one year high of $18.33. The firm has a market capitalization of $418.71 million, a PE ratio of -49.10, a price-to-earnings-growth ratio of 6.76 and a beta of 0.38.

Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The business services provider reported ($0.01) EPS for the quarter, missing analysts' consensus estimates of $0.07 by ($0.08). The company had revenue of $274.07 million for the quarter, compared to analyst estimates of $292.67 million. Cross Country Healthcare had a positive return on equity of 1.72% and a negative net margin of 0.70%. Analysts expect that Cross Country Healthcare, Inc. will post 0.53 EPS for the current fiscal year.

Cross Country Healthcare Profile

(Free Report)

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.

Featured Articles

Institutional Ownership by Quarter for Cross Country Healthcare (NASDAQ:CCRN)

Should You Invest $1,000 in Cross Country Healthcare Right Now?

Before you consider Cross Country Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.

While Cross Country Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

September Rate Cuts: 3 Stocks Set to Benefit Most
Markets Are Sliding: Where to Find Opportunity
5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines